An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 500/10 mg and Coadministration of Metformin SR 500 mg and Rosuvastatin 10 mg in Healthy Volunteers

Trial Profile

An Open-label, Randomized, Single-dose Crossover Study to Compare the Pharmacokinetics After the Administration of HCP1201 Tablet 500/10 mg and Coadministration of Metformin SR 500 mg and Rosuvastatin 10 mg in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Metformin/rosuvastatin (Primary) ; Metformin; Rosuvastatin
  • Indications Hyperlipidaemia; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Hanmi Pharmaceutical
  • Most Recent Events

    • 06 Feb 2014 New source identified and integrated (Korean Clinical Trials Register)
    • 06 Feb 2014 Status changed from active, no longer recruiting to completed as reported by Korean Clinical Trials Register
    • 17 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top